My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$EBAY {{ '2015-07-16T13:55:08+0000' | timeago}} • Webcast

$EBAY 2Q15 Call: In terms of TPV growth, Dan said that looking at TPV results over last several quarters, one can see strong and accelerating TPV growth, which was 36% in 2Q15. He added that the company has a balanced portfolio across the world and across the product mix, and is seeing good strength driving TPV and revenue.

User Frankie Joe {{ '2017-02-28T13:37:27+0000' | timeago}}

Samsung's not looking good! South Korea will indict their top boss-to-be Lee Jae-yong for corruption.

User Ashton Alloway {{ '2017-02-28T12:20:18+0000' | timeago}}

$TWTR mentions Snap as one of its fiercest rivals in its 10K filing. Great head start for Snap ahead of IPO!

User Johney Kingston {{ '2017-02-27T20:48:18+0000' | timeago}}

$WMT has indeed intensified the grocery price competition..Watch out $KR and Aldi.

User Felix Nilsson {{ '2017-02-27T20:41:52+0000' | timeago}}

The increasing US oil output seems to offset the bets raised by investors a week ago on increasing Brent crude oil prices.

User Nick Velez {{ '2017-02-27T20:22:11+0000' | timeago}}

Treasury yields moved higher on Monday as investors were cautious to make big government bonds investments ahead of President Donald Trump's first congressional address.

$O {{ '2017-02-28T14:31:27+0000' | timeago}} • Announcement

$O commenced an underwritten public offering of 8MM common shares. The company intends to grant underwriters a 30-day option to buy up to 1.2MM additional shares.

$PRGO {{ '2017-02-28T14:30:10+0000' | timeago}} • Announcement

$PRGO agreed to divest Tysabri royalty stream. Royalty Pharma will buy all of $PRGO's rights to receive Tysabri royalty payments from and after Jan. 1, 2017, which $PRGO has under agreement with $BIIB. Tysabri is FDA approved treatment for multiple sclerosis. $PRGO acquired Tysabri royalty stream rights through 2013 acquisition of Elan Corp. plc.

$PRGO {{ '2017-02-28T14:25:16+0000' | timeago}} • Announcement

$PRGO agreed to divest Tysabri royalty stream for up to $2.85Bil. The consideration composed of $2.2Bil in cash at closing and up to $650MM in potential milestone payments based upon future global net sales of Tysabri in 2018 and 2020.

$ESV {{ '2017-02-28T14:24:36+0000' | timeago}} • Announcement

During 4Q16, $ESV's Floater revenues declined 38% YoY to $303MM,due to fewer rig operating days. Jackup revenues fell 39% to $187MM, mainly due to fewer rig operating days.

$ESV {{ '2017-02-28T14:20:31+0000' | timeago}} • Announcement

Offshore drilling company $ESV reported 4Q16 net income of $39MM, or $0.13 per share, compared to net loss of $2.47Bil, or $10.64 per share during 4Q15. Revenues declined 39% YoY to $505MM, mainly due to decline in reported utilization to 51%.